Relationship Between Platelet Activation and Acute Rejection After Renal Transplantation

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1547-1551

  Zhang, Y ^a   Zhang, X D ^a   Ma, L L ^a   Guan, D L ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD42A ANTIGEN; CD61 ANTIGEN; CD63 ANTIGEN; CELL MARKER; CREATININE; CYCLOSPORIN; DEXAMETHASONE; DUAL SPECIFICITY PHOSPHATASE 2; MEMBRANE PROTEIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PADGEM PROTEIN; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ADULT; AGED; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG MEGADOSE; EARLY DIAGNOSIS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; THROMBOCYTE ACTIVATION; UREMIA;

ACUTE DISEASE; ADULT; AGED; ANTIGENS, CD; DRUG THERAPY, COMBINATION; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTEGRIN BETA3; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET MEMBRANE GLYCOPROTEINS; RENAL DIALYSIS; YOUNG ADULT;

EID: 67249114825     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.04.006     Document Type: Article

References (17)

1. Bustos M., Saadi S., and Platt J.L. Platelet-mediated activation of endothelial cells: implications for the pathogenesis of transplant rejection. Transplantation 72 (2001) 509
2. Meehan S.M., Limsrichamrem S., Manaligod J.R., et al. Platelets and capillary injury in acute humoral rejection of renal allografts. Hum Pathol 34 (2003) 533
3. Abrams C.S. Intracellular signaling in platelets. Curr Opin Hematol 12 (2005) 401
4. Breddin H.K. Can platelet aggregometry be standardized?. Platelets 16 (2005) 151
5. von Hundelshausen P., Petersen F., and Brandt E. Platelet-derived chemokines in vascular biology. Thromb Haemost 97 (2007) 704
6. Amabile N., Guerin A.P., Leroyer A., et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 16 (2005) 3381
7. Angiolillo D.J., Femandez A., Bemdrao E., et al. Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes 54 (2005) 2430
8. Zhang Y., Guan D.L., Xia C.Q., et al. The relationship between the peripheral blood of CD61, CD63, PAC-1 and the transplant kidney function. Transplant Proc 35 (2003) 1360
9. 1 inhibiting platelet activation in AR after kidney transplantation. Transplant Proc 37 (2005) 2408
10. Fogari R., and Zoppi A. Is the effect of antihypertensive drugs on platelet aggregability and fibrinolysis clinically relevant?. Am J Cardiovasc Drug 5 (2005) 211
11. Chiang T.M. Recent development of peptides from glycoproteins IIb (alphaIIb) and IIIa (beta3) that inhibit platelet fibrinogen binding. Curr Med Chem Cardiovasc Hematol Agents 3 (2005) 99
12. Golino P., Loffredo F., Riegler L., et al. Novel antithrombotic strategies in cardiovascular diseases. Curr Opin Invest Drugs 6 (2005) 298
13. Rumbaut R.E., and Slaff D.W. Microvascular thrombosis models in venules and arterioles in vivo. Microcirculation 12 (2005) 259
14. Chen J., and Lopez J.A. Interactions of platelets with subendothelium and endothelium. Microcirculation 12 (2005) 235
15. Rother R.P., Bell L., Hillmen P., et al. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 293 (2005) 1653
16. Kondo K., and Umemura K. Clinical pharmacokinetics of tirofiban, a nonpeptide glycoprotein IIb/IIIa receptor antagonist: comparison with the monoclonal antibody abciximab. Clin Pharmacokinet 41 (2002) 187
17. Colwell J.A. Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus. Am J Cardiovasc Drugs 4 (2004) 87